Clinical characteristics of clear cell carcinoma of the ovary

Gynecologic Oncology

Volumn 70, Issue 2, 1998, Pages 255-258

  Behbakht, Kian ^a   Randall, Thomas C ^a   Benjamin, Ivor ^a   Morgan, Mark A ^a   King, Stephanie ^a   Rubin, Stephen C ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; ALTRETAMINE; CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL; TOPOTECAN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOSENSITIVITY; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; MINIMAL RESIDUAL DISEASE; OVARY CARCINOMA; PRIORITY JOURNAL; SECOND LOOK SURGERY;

EID: 0032143851     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5071     Document Type: Article

References (21)

1. Schiller W. Mesonephroma ovarii. Int J Cancer. 35:1929;1.
2. Teilum G. Gonocytoma: homologous ovarian and testicular tumours. Acta Pathol Microbiol Scand. 23:1946;242.
3. Scully R E. Recent progress in ovarian cancer. Hum Pathol. 1:1970;73.
4. Serov S F, Scully R E, Sobin L H. International Histologic Classification of Tumors. No. 9. Histologic Typing of Ovarian Tumors. 1973;World Health Organization, Geneva.
5. Kennedy A W, Biscotti C V, Hart W R, Webster K D. Ovarian clear cell adenocarcinoma. Gynecol Oncol. 32:1989;342-349.
6. Jenison E L, Montag A G, Griffiths C T, Welch W R, Lavin P T, Greer J, Knapp R C. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol Oncol. 32:1989;65-71.
7. Hameed K, Burslem M RG, Tupper W RC. Clear cell carcinoma of the ovary. Cancer. 24:1969;452-459.
8. Ohkawa K, Amasaki H, Terashima Y, Aizawa S, Ishikawa E. Clear cell carcinoma of the ovary. Cancer. 40:1977;3019-3029.
9. Shevchuk M M, Winkler-Monsanto B, Fenoglio C M, Richart R M. Clear cell carcinoma of the ovary: a clinicopathologic study with review of the literature. Cancer. 47:1981;1344-1351.
10. Yoonessi M, Weldon D, Satchidand S K, Crickard K. Clear cell ovarian adenocarcinoma. J Surg Oncol. 27:1984;289-297.
11. Benjamin I, Noumoff J S, Carlson J A, Giuntoli R L, Morgan M A, Mikuta J J. Database management for a gynecologic oncology service. Gynecol Oncol. 38:1990;431-436.
12. Gynecologic Oncology Group Surgical Procedures Manual. Nov 3, 1994.
13. Takahashi H, Behbakht K, McGovern P E, Chiu H-C, Couch F J, Weber B L, Friedman L S, King M C, Furusato M, LiVolsi V A, Menzin A W, Liu P C, Benjamin I, Morgan M A, King S A, Rebane B A, Cardonick A, Mikuta J J, Rubin S C, Boyd J. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res. 55:1995;2998-3002.
14. Takashi H, Chiu H-C, Bandera C A, Behbakht K, Liu P C, Couch F J, Weber B L, LiVolsi V A, Furusato M, Rebane B A, Cardonick A, Benjamin I, Morgan M A, King S A, Mikuta J J, Rubin S C, Boyd J. Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res. 56:1996;2738-2741.
15. Crozier M A, Copeland L J, Silva E G, Gershenson D M, Stringer C A. Clear cell carcinoma of the ovary: a study of 59 cases. Gynecol Oncol. 35:1989;199-203.
16. O'Brien M ER, Schofield J B, Tan S, Fryatt I, Fisher C, Wiltshaw E. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol. 49:1993;250-254.
17. Kishikawa T, Sakamoto M, Ino Y, Kubushiro K, Nozawa S, Hirohashi S. Two distinct patterns of peritoneal involvement shown by in vitro and in vivo ovarian cancer dissemination models. Invasion Metastasis. 15:1995;11-21.
18. Mok S C, Bell D A, Knapp R C, Fishbaugh P M, Welch W R, Muto M G, Berkowitz R S, Tsao S W. Mutation of K-tas protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 53:1993;1489-1492.
19. Hreshchyshyn M M, Park R C, Blessing J A, Norris H J, Levy D, Lagasse L D, Creasman W T. The role of adjuvant therapy in stage I ovarian cancer. Am J Obstet Gynecol. 138:1980;139.
20. Gorai I, Nakazawa T, Miyagi E, Hirahara F, Nagashima Y, Minaguchi H. Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties. Gynecol Oncol. 57:1995;33-46.
21. Goff B A, Sainz de la Cuesta R, Muntz H G, Fleischhacker D, Ek M, Rice L W, Nikrui N, Tamimi H K, Cain J M, Greer B E, Fuller A F Jr. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol. 60:1996;412-417.